Abdominal obesity and metabolic syndrome
暂无分享,去创建一个
[1] F. Schmidt. Meta-Analysis , 2008 .
[2] S. Pincock. Paul Zimmet: fighting the “diabesity” pandemic , 2006, The Lancet.
[3] Jiang He,et al. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. , 2006, The American journal of medicine.
[4] N. Sattar. The metabolic syndrome: should current criteria influence clinical practice? , 2006, Current Opinion in Lipidology.
[5] R. Eckel,et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.
[6] V. Drapeau,et al. Waist Girth Does Not Predict Metabolic Complications in Severely Obese Men A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.
[7] S. Grundy. Does a diagnosis of metabolic syndrome have value in clinical practice? , 2006, The American journal of clinical nutrition.
[8] G. Reaven,et al. The metabolic syndrome: is this diagnosis necessary? , 2006, The American journal of clinical nutrition.
[9] Paul M Ridker,et al. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.
[10] S. Grundy. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy , 2006, Nature Reviews Drug Discovery.
[11] S. Grundy,et al. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.
[12] L. Tavazzi,et al. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. , 2006, American heart journal.
[13] Richard N Bergman,et al. Why Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome , 2006, Obesity.
[14] M. Jensen. Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model , 2006, Obesity.
[15] J. Després,et al. Is visceral obesity the cause of the metabolic syndrome? , 2006, Annals of medicine.
[16] E. Ferrannini. Is insulin resistance the cause of the metabolic syndrome? , 2006, Annals of medicine.
[17] Richard W Morris,et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.
[18] R. D'Agostino,et al. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.
[19] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[20] Richard Kahn,et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.
[21] H. Lebovitz,et al. Point: visceral adiposity is causally related to insulin resistance. , 2005, Diabetes care.
[22] E. Gale. The myth of the metabolic syndrome , 2005, Diabetologia.
[23] G. Reaven. The metabolic syndrome: requiescat in pace. , 2005, Clinical chemistry.
[24] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[25] S. Fowler,et al. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.
[26] J. Després,et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. , 2005, The Journal of clinical endocrinology and metabolism.
[27] Muredach P. Reilly,et al. Mechanisms of the metabolic syndrome , 2004 .
[28] S. Haffner,et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.
[29] P. Underwood. Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist. , 2004, Current opinion in lipidology.
[30] A. Garg,et al. Lipodystrophies: rare disorders causing metabolic syndrome. , 2004, Endocrinology and metabolism clinics of North America.
[31] I. Lemieux. Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[32] Claude Lenfant,et al. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[33] A. Gotto,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.
[34] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[35] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[36] H. Kahn,et al. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. , 2003, The American journal of clinical nutrition.
[37] C. Bouchard,et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. , 2003, Medicine and science in sports and exercise.
[38] T. Jørgensen,et al. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): Relationship to metabolic risk factors , 2003, International Journal of Obesity.
[39] P. Tsao,et al. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? , 2003, Journal of the American College of Cardiology.
[40] L. Niskanen,et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. , 2002, American journal of epidemiology.
[41] P. Libby,et al. Diabetic macrovascular disease: the glucose paradox? , 2002, Circulation.
[42] Ronald Klein,et al. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. , 2002, Diabetes care.
[43] S. Heymsfield,et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. , 2002, The American journal of clinical nutrition.
[44] Moyses Szklo,et al. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. , 2002, Diabetes.
[45] Tracey McLaughlin,et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. , 2002, Journal of the American College of Cardiology.
[46] J. Hardies,et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. , 2002, The Journal of clinical endocrinology and metabolism.
[47] S. Haffner,et al. Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.
[48] R. Bergman,et al. Extreme insulin resistance of the central adipose depot in vivo. , 2002, Diabetes.
[49] P. Havel. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin , 2002, Current opinion in lipidology.
[50] G. Assmann,et al. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.
[51] J. Shaw,et al. Global and societal implications of the diabetes epidemic , 2001, Nature.
[52] M. Dumont,et al. Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men , 2001, International Journal of Obesity.
[53] J. Després,et al. Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[54] A. Leon,et al. Response of blood lipids to exercise training alone or combined with dietary intervention. , 2001, Medicine and science in sports and exercise.
[55] T. Rice,et al. FAMILIAL AGGREGATION OF CARDIOVASCULAR RESPONSE TO SUBMAXIMAL EXERCISE IN THE HERITAGE FAMILY STUDY , 2001 .
[56] J. Després,et al. Treatment of obesity: need to focus on high risk abdominally obese patients , 2001, BMJ : British Medical Journal.
[57] GS Hotamisligil,et al. Molecular mechanisms of insulin resistance and the role of the adipocyte , 2000, International Journal of Obesity.
[58] A. Astrup,et al. Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’? , 2000, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[59] R. Hegele. Insulin resistance in human partial lipodystrophy , 2000, Current atherosclerosis reports.
[60] E. Danforth. Failure of adipocyte differentiation causes type II diabetes mellitus? , 2000, Nature Genetics.
[61] C. Bouchard,et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[62] Robert Ross,et al. Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men , 2000, Annals of Internal Medicine.
[63] D. Gaudet,et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.
[64] G. Shulman,et al. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.
[65] G. Shulman,et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.
[66] M. Laakso,et al. Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.
[67] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[68] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[69] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[70] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[71] J. Conway,et al. Intraabdominal adipose tissue and anthropometric surrogates in African American women with upper- and lower-body obesity. , 1997, The American journal of clinical nutrition.
[72] J. Albu,et al. Visceral Fat and Race-Dependent Health Risks in Obese Nondiabetic Premenopausal Women , 1997, Diabetes.
[73] J. Lovejoy,et al. Abdominal fat distribution and metabolic risk factors: effects of race. , 1996, Metabolism: clinical and experimental.
[74] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[75] E. Shafrir,et al. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. , 1996, Diabetes & metabolism.
[76] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[77] C. Morrison,et al. Waist circumference as a measure for indicating need for weight management , 1995, BMJ.
[78] J. Després,et al. Regional variation in adipose tissue metabolism of severely obese premenopausal women. , 1995, Journal of lipid research.
[79] A. Kissebah,et al. Regional adiposity and morbidity. , 1994, Physiological reviews.
[80] A Tremblay,et al. Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.
[81] P. Björntorp. Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.
[82] A Tremblay,et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.
[83] A Tremblay,et al. The response to long-term overfeeding in identical twins. , 1990, The New England journal of medicine.
[84] E. Barrett-Connor,et al. Cigarette smoking and increased central adiposity. , 1989, Annals of internal medicine.
[85] R. Andres,et al. Studies in the distribution of body fat. III. Effects of cigarette smoking. , 1989, JAMA.
[86] J. File. Requiescat in pace. , 1987, Canadian family physician Medecin de famille canadien.
[87] J. Després,et al. We-S14:3 From CVD risk to cardiometabolic risk , 2006 .
[88] Y. Matsuzawa. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.
[89] Neil R. Powe,et al. The Atherosclerosis Risk in Communities Study , 2006 .
[90] D. Moller,et al. Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.
[91] R. Califf,et al. Metabolic syndrome: definition, pathophysiology, and mechanisms. , 2005, American heart journal.
[92] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[93] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[94] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[95] M. Moore. Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. , 1998, Journal of insurance medicine.